These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36271699)

  • 21. Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
    Acet-Öztürk NA; Ömer-Topçu D; Vurat-Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Akalın H; Özkalemkaş F; Ener B; Ali R
    J Mycol Med; 2022 Nov; 32(4):101304. PubMed ID: 35738036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of interleukin 6 and interferon gamma in the differentiation of invasive pulmonary aspergillosis and pneumocystis pneumonia in pediatric oncology patients.
    Shen HP; Tang YM; Song H; Xu WQ; Yang SL; Xu XJ
    Int J Infect Dis; 2016 Jul; 48():73-7. PubMed ID: 27208634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis.
    Jung J; Kim MY; Lee HJ; Park YS; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Clin Microbiol Infect; 2015 Jul; 21(7):684.e11-8. PubMed ID: 25882362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Gu Y; Ye X; Liu Y; Wang Y; Shen K; Zhong J; Chen B; Su X
    Respir Res; 2021 Jun; 22(1):176. PubMed ID: 34107968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive pulmonary aspergillosis in heart transplant recipients: two radiologic patterns with a different prognosis.
    Muñoz P; Vena A; Cerón I; Valerio M; Palomo J; Guinea J; Escribano P; Martínez-Sellés M; Bouza E;
    J Heart Lung Transplant; 2014 Oct; 33(10):1034-40. PubMed ID: 25012980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.
    Huang L; He H; Jin J; Zhan Q
    BMC Infect Dis; 2017 Mar; 17(1):209. PubMed ID: 28292284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.
    Eigl S; Prattes J; Lackner M; Willinger B; Spiess B; Reinwald M; Selitsch B; Meilinger M; Neumeister P; Reischies F; Wölfler A; Raggam RB; Flick H; Eschertzhuber S; Krause R; Buchheidt D; Thornton CR; Lass-Flörl C; Hoenigl M
    Crit Care; 2015 Apr; 19(1):178. PubMed ID: 25927915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients.
    Kami M; Tanaka Y; Kanda Y; Ogawa S; Masumoto T; Ohtomo K; Matsumura T; Saito T; Machida U; Kashima T; Hirai H
    Haematologica; 2000 Jul; 85(7):745-52. PubMed ID: 10897127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of invasive pulmonary aspergillosis in 21 children with non-hematologic diseases].
    Zhang XY; Zhao SY; Qian SY; Hu YH; Zeng JJ; Jiang ZF
    Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):730-4. PubMed ID: 20021805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
    Thornton C; Johnson G; Agrawal S
    J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis values of IL-6 and IL-8 levels in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    Liu F; Zhang X; Du W; Du J; Chi Y; Sun B; Song Z; Shi J
    J Investig Med; 2021 Oct; 69(7):1344-1349. PubMed ID: 34127514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography findings are different between invasive and noninvasive pulmonary aspergillosis.
    Kim JY; Yoo JW; Oh M; Park SH; Shim TS; Choi YY; Ryu JS
    J Comput Assist Tomogr; 2013; 37(4):596-601. PubMed ID: 23863538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep Learning Models to Predict Fatal Pneumonia Using Chest X-Ray Images.
    Anai S; Hisasue J; Takaki Y; Hara N
    Can Respir J; 2022; 2022():8026580. PubMed ID: 36465274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
    Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT features and clinical characteristics of invasive pulmonary aspergillosis complicated with hematopathy.
    Wu Y; Huang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):973-979. PubMed ID: 33053541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?
    Horger M; Hebart H; Einsele H; Lengerke C; Claussen CD; Vonthein R; Pfannenberg C
    Eur J Radiol; 2005 Sep; 55(3):437-44. PubMed ID: 16129254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.